Stephen J. Tulipano
2018 - Aldeyra Therapeutics
In 2018, Stephen J. Tulipano earned a total compensation of $884.4K as former chief financial officer at Aldeyra Therapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $124,704 |
|---|---|
| Option Awards | $397,801 |
| Salary | $356,296 |
| Other | $5,567 |
| Total | $884,368 |
Tulipano received $397.8K in option awards, accounting for 45% of the total pay in 2018.
Tulipano also received $124.7K in non-equity incentive plan, $356.3K in salary and $5.6K in other compensation.
Rankings
In 2018, Stephen J. Tulipano's compensation ranked 9,759th out of 14,244 executives tracked by ExecPay. In other words, Tulipano earned more than 31.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,759 out of 14,244 | 32nd |
Division Manufacturing | 3,938 out of 5,762 | 32nd |
Major group Chemicals And Allied Products | 1,478 out of 2,125 | 30th |
Industry group Drugs | 1,245 out of 1,814 | 31st |
Industry Pharmaceutical Preparations | 957 out of 1,388 | 31st |
Source: SEC filing on April 22, 2019.
Tulipano's colleagues
We found three more compensation records of executives who worked with Stephen J. Tulipano at Aldeyra Therapeutics in 2018.